| Clinical characteristics and outcomes of oropharyngeal carcinoma related to high‐risk non–human papillomavirus16 viral subtypes I Varier, BR Keeley, R Krupar, A Patsias, J Dong, N Gupta, AK Parasher, ... Head & Neck 38 (9), 1330-1337, 2016 | 43 | 2016 |
| Immunometabolic determinants of chemoradiotherapy response and survival in head and neck squamous cell carcinoma R Krupar, MG Hautmann, RR Pathak, I Varier, C McLaren, D Gaag, ... The American Journal of Pathology 188 (1), 72-83, 2018 | 24 | 2018 |
| Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes JR Montealegre, I Varier, CG Bracamontes, LM Dillon, M Guillaud, ... Ethnicity & health, 1-12, 2017 | 17 | 2017 |
| Racial disparities in incidence of human papillomavirus-associated oropharyngeal cancer in an urban population I Ramer, I Varier, D Zhang, EG Demicco, MR Posner, K Misiukiewicz, ... Cancer Epidemiology 44, 91-95, 2016 | 11 | 2016 |
| Use of audiometric measurement for assessment of vocal-fold function in postextubation infants YCC Liu, I Varier, J Ongkasuwan JAMA Otolaryngology–Head & Neck Surgery 143 (9), 908-911, 2017 | 8 | 2017 |
| Prognostic significance of histologic features in HPV-associated tonsillar squamous cell carcinoma J Jing, I Varier, J Dong, D Zhang, AG Sikora, EG Demicco LABORATORY INVESTIGATION 96, 323A-324A, 2016 | 2 | 2016 |
| Abstract PR005: TGF-beta1 primed myeloid derived suppressor cells decrease tumor growth and lose their ability to inhibit T cell proliferation via iNOS downregulation P Jayaraman, F Parikh, R Krupar, R Parihar, I Varier, A Sikora Cancer Immunology Research 4 (1_Supplement), PR005-PR005, 2016 | 1 | 2016 |
| The Role of Targeted Therapies or Nonsurgical Treatment of Thyroid Malignancies: Is Surgery Being Replaced? DC McFarland, I Varier, K Misiukiewicz Controversies in Thyroid Surgery, 203-228, 2016 | 1* | 2016 |
| Piperacillin/tazobactam/vancomycin I Varier Reactions 1696, 311-7, 2018 | | 2018 |
| Concomitant acute tubular interstitial nephritis and acute tubular necrosis in a child treated with vancomycin and piperacillin/tazobactam I Varier, C Mertens, R Steele Journal of Investigative Medicine, 2018 | | 2018 |
| JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK JJ Beitler, CU Jones, JK Salama, PM Busse, JS Cooper, SA Koyfman, ... | | 2016 |
| Key Papers in Cancer Epidemiology R Newton, D Whitby, BJM Peters, V Janssen, FM Schramel, ... Epidemiology 42, 199-205, 2016 | | 2016 |
| Abstract PR06: Racial/ethnic variation in the prevalence of vaccine-preventable human papillomavirus genotypes I Varier, JR Montealegre, CM Gutierrez, LM Dillon, M Guillaud, KA Storthz, ... Cancer Epidemiology, Biomarkers & Prevention 25 (3_Supplement), PR06-PR06, 2016 | | 2016 |
| TGF-betal primed myeloid derived suppressor cells decrease tumor growth and lose their ability to inhibit T cell proliferation via iNOS downregulation P Jayaraman, F Parikh, R Krupar, R Parihar, I Varier, A Sikora CANCER IMMUNOLOGY RESEARCH 4 (1), 2016 | | 2016 |
| Systematic Review of HPV-Related Head and Neck Cancers in Latin American Countries AW Chu, IV Varier, A Patsias, AG Sikora Otolaryngology—Head and Neck Surgery 151 (1_suppl), P48-P48, 2014 | | 2014 |
| Racial Disparities in Incidence of Human Papillomavirus–Associated Oropharyngeal Cancer in an Urban Population I Ramer, IV Varier, DY Zhang, E Demicco, M Posner, K Misiukiewicz, ... Otolaryngology–Head and Neck Surgery 151, P46-P47, 2014 | | 2014 |
| DECREASING ANTIBIOTIC USE BY IMPLEMENTING 36-HOUR RULE OUT GUIDELINES DOF CHANGE | | |
| Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma. R Krupar, MG Hautmann, RR Pathak, I Varier, C McLaren, D Gaag, ... | | |
| Clinical Characteristics And Outcomes Of Hpv33/35-related Oropharyngeal Cancer I Varier, B Keeley, A Patsias, E Genden, B Miles, M Teng, R Bakst, ... | | |
Andrew G. SikoraUniversity of Texas MD Anderson Cancer CenterVerified email at bcm.edu
